{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Hydroxyurea", "Nutrient deficiencies", "Nutritional approaches", "Sickle cell disease", "Vaso-occlusive crisis"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "27508000", "DateCompleted": {"Year": "2016", "Month": "08", "Day": "10"}, "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2016", "Month": "08", "Day": "08"}], "ELocationID": ["50", "10.1186/s12986-016-0109-7"], "Journal": {"ISSN": "1743-7075", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2016"}}, "Title": "Nutrition & metabolism", "ISOAbbreviation": "Nutr Metab (Lond)"}, "ArticleTitle": "Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration.", "Pagination": {"StartPage": "50", "MedlinePgn": "50"}, "Abstract": {"AbstractText": ["Nutritional research in sickle cell disease has been the focus in recent times owing to not only specific nutritional deficiencies, but also the improvements associated with less painful episodes. Though hydroxyurea remains the drug of choice, certain adverse health effects on long term supplementation makes room for researches of different compounds. Macro and micro nutrient deficiencies, along with vitamins, play an important role in not only meeting the calorific needs, but also reducing clinical complications and growth abnormalities. Symptoms of hyper protein metabolism, increased cell turnover, increased cardiac output, and appetite suppression due to enhanced cytokine production, might give us leads for better understanding of the mechanisms involved. Different nutritional approaches comprising of traditional herbal therapies, antioxidants, flavonoids, vitamins, minerals etc., reducing oxidative stress and blood aggregation, have been tried out to increase the health potential. Nutritional therapies may also serve complementary to the newer therapies using ozone, hematopoietic stem cell transplantation, antifungal medications, erythropoietin etc. Herein we try to present a holistic picture of the different patho-physiological mechanisms, and nutritional strategies adopted."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah, 21589 Kingdom of Saudi Arabia."}], "LastName": "Khan", "ForeName": "Shahida A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah, 21589 Kingdom of Saudi Arabia."}], "LastName": "Damanhouri", "ForeName": "Ghazi", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah, 21589 Kingdom of Saudi Arabia."}], "LastName": "Ali", "ForeName": "Ashraf", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Brain Research Center, Manesar, Gurgaon, 122051 India."}], "LastName": "Khan", "ForeName": "Sarah A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah, 21589 Kingdom of Saudi Arabia."}], "LastName": "Khan", "ForeName": "Aziz", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Ave., Brooklyn, New York 11203 United State of America (USA)."}], "LastName": "Bakillah", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hematology, King Fahd Hospital of the Armed forces, Jeddah, Kingdom of Saudi Arabia ; Department of Medical Laboratory, King Fahd Hospital of the Armed forces, Jeddah, Kingdom of Saudi Arabia."}], "LastName": "Marouf", "ForeName": "Samy", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hematology, Soliman Fakeeh Hospital Jeddah, Jeddah, Kingdom of Saudi Arabia."}], "LastName": "Al Harbi", "ForeName": "Ghazi", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hematology, Umm Al Qura University, Faculty of Medicine, Makkah, Kingdom of Saudi Arabia."}], "LastName": "Halawani", "ForeName": "Saeed H", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah, 21589 Kingdom of Saudi Arabia."}], "LastName": "Makki", "ForeName": "Ahmad", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Nutr Metab (Lond)", "NlmUniqueID": "101231644", "ISSNLinking": "1743-7075"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79:704\u2013712.", "ArticleIdList": ["PMC2566499", "11545326"]}, {"Citation": "Adorno EV, Zanette A, Lyra I, Souza CC, Santos LF, Menezes JF, Dupuit MF, Almeida MN, Reis MG, Goncalves MS. The beta-globin gene cluster haplotypes in sickle cell anemia patients from Northeast Brazil: a clinical and molecular view. Hemoglobin. 2004;28:267\u2013271. doi: 10.1081/HEM-120040310.", "ArticleIdList": ["10.1081/HEM-120040310", "15481897"]}, {"Citation": "Steinberg MH. Review: sickle cell disease: present and future treatment. Am J Med Sci. 1996;312:166\u2013174. doi: 10.1016/S0002-9629(15)41800-2.", "ArticleIdList": ["10.1016/S0002-9629(15)41800-2", "8853065"]}, {"Citation": "Steinberg MH. In the clinic. Sickle cell disease. Ann Intern Med. 2011;155:ITC31\u201315. doi: 10.7326/0003-4819-155-5-201109060-01003.", "ArticleIdList": ["10.7326/0003-4819-155-5-201109060-01003", "21893620"]}, {"Citation": "Wandersee NJ, Punzalan RC, Rettig MP, Kennedy MD, Pajewski NM, Sabina RL, Paul Scott J, Low PS, Hillery CA. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume. Br J Haematol. 2005;131:366\u2013377. doi: 10.1111/j.1365-2141.2005.05767.x.", "ArticleIdList": ["10.1111/j.1365-2141.2005.05767.x", "16225657"]}, {"Citation": "Embury SH. The Not\u2010So\u2010Simple Process of Sickle Cell Vasoocclusion. Microcirculation. 2004;11:101\u2013113. doi: 10.1080/10739680490278277.", "ArticleIdList": ["10.1080/10739680490278277", "15280086"]}, {"Citation": "Chakravorty S, Williams TN. Sickle cell disease: a neglected chronic disease of increasing global health importance. Arch Dis Child. 2015;100:48\u201353. doi: 10.1136/archdischild-2013-303773.", "ArticleIdList": ["10.1136/archdischild-2013-303773", "PMC4285890", "25239949"]}, {"Citation": "Stevens MC, Maude GH, Beckford M, Grandison Y, Mason K, Taylor B, Serjeant BE, Higgs DR, Teal H, Weatherall DJ, et al. Alpha thalassemia and the hematology of homozygous sickle cell disease in childhood. Blood. 1986;67:411\u2013414.", "ArticleIdList": ["2417644"]}, {"Citation": "Adewoyin AS. Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa) Anemia. 2015;2015:791498. doi: 10.1155/2015/791498.", "ArticleIdList": ["10.1155/2015/791498", "PMC4312619", "25667774"]}, {"Citation": "Pace BS, Liu L, Li B, Makala LH. Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease. Exp Biol Med (Maywood) 2015;240:1050\u20131064. doi: 10.1177/1535370215596859.", "ArticleIdList": ["10.1177/1535370215596859", "PMC4935285", "26283707"]}, {"Citation": "Hirst C, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev. 2014;11:CD003427.", "ArticleIdList": ["25375222"]}, {"Citation": "Hirst C, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev. 2012;9:CD003427.", "ArticleIdList": ["22972063"]}, {"Citation": "Crowley PD, Gallagher HC. Clotrimazole as a pharmaceutical: past, present and future. J Appl Microbiol. 2014;117:611\u2013617. doi: 10.1111/jam.12554.", "ArticleIdList": ["10.1111/jam.12554", "24863842"]}, {"Citation": "van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol. 2007;82:955\u2013960. doi: 10.1002/ajh.20944.", "ArticleIdList": ["10.1002/ajh.20944", "17617790"]}, {"Citation": "Birken CS, Khambalia A, Dupuis A, Pastor A, Lee M, Padavattan K, Mekky M, Odame I, Parkin PC. Morphine is associated with acute chest syndrome in children hospitalized with sickle cell disease. Hosp Pediatr. 2013;3:149\u2013155. doi: 10.1542/hpeds.2012-0067.", "ArticleIdList": ["10.1542/hpeds.2012-0067", "24340416"]}, {"Citation": "Talano JA, Cairo MS. Hematopoietic stem cell transplantation for sickle cell disease: state of the science. Eur J Haematol. 2015;94:391\u2013399. doi: 10.1111/ejh.12447.", "ArticleIdList": ["10.1111/ejh.12447", "25200500"]}, {"Citation": "Kawchak DA, Schall JI, Zemel BS, Ohene-Frempong K, Stallings VA. Adequacy of dietary intake declines with age in children with sickle cell disease. J Am Diet Assoc. 2007;107:843\u2013848. doi: 10.1016/j.jada.2007.02.015.", "ArticleIdList": ["10.1016/j.jada.2007.02.015", "17467383"]}, {"Citation": "Daak AA, Ghebremeskel K, Hassan Z, Attallah B, Azan HH, Elbashir MI, Crawford M. Effect of omega-3 (n\u2009\u2212\u20093) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2013;97:37\u201344. doi: 10.3945/ajcn.112.036319.", "ArticleIdList": ["10.3945/ajcn.112.036319", "23193009"]}, {"Citation": "Riddington C, De Franceschi L. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev 2002;4:CD003426.", "ArticleIdList": ["12519597"]}, {"Citation": "Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anemia: a potential nutritional approach for a molecular disease. Nutrition. 2000;16:330\u2013338. doi: 10.1016/S0899-9007(00)00257-4.", "ArticleIdList": ["10.1016/S0899-9007(00)00257-4", "10793299"]}, {"Citation": "Serjeant GR. The emerging understanding of sickle cell disease. Br J Haematol. 2001;112:3\u201318. doi: 10.1046/j.1365-2141.2001.02557.x.", "ArticleIdList": ["10.1046/j.1365-2141.2001.02557.x", "11167776"]}, {"Citation": "Mandese V, Marotti F, Bedetti L, Bigi E, Palazzi G, Iughetti L. Effects of nutritional intake on disease severity in children with sickle cell disease. Nutr J. 2016;15:46. doi: 10.1186/s12937-016-0159-8.", "ArticleIdList": ["10.1186/s12937-016-0159-8", "PMC4851811", "27130184"]}, {"Citation": "Martyres DJ, Vijenthira A, Barrowman N, Harris-Janz S, Chretien C, Klaassen RJ. Nutrient Insufficiencies/Deficiencies in Children With Sickle Cell Disease and Its Association With Increased Disease Severity. Pediatr Blood Cancer. 2016;63(6):1060\u20134. doi: 10.1002/pbc.25940.", "ArticleIdList": ["10.1002/pbc.25940", "26855061"]}, {"Citation": "Akohoue SA, Shankar S, Milne GL, Morrow J, Chen KY, Ajayi WU, Buchowski MS. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res. 2007;61:233\u2013238. doi: 10.1203/pdr.0b013e31802d7754.", "ArticleIdList": ["10.1203/pdr.0b013e31802d7754", "17237728"]}, {"Citation": "Hundekar PS, Suryakar AN, Karnik AC, Katkam RV, Joshi NG, Ghone RA. Level of nitric oxide and antioxidant vitamins in sickle cell anaemia patients. Indian J Physiol Pharmacol. 2012;56:125\u2013129.", "ArticleIdList": ["23387240"]}, {"Citation": "Hyacinth HI, Capers PL, Archer DR, Hibbert JM. TNF-alpha, IFN-gamma, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet. Exp Biol Med (Maywood) 2014;239:65\u201370. doi: 10.1177/1535370213508357.", "ArticleIdList": ["10.1177/1535370213508357", "PMC4164018", "24281564"]}, {"Citation": "Archer DR, Stiles JK, Newman GW, Quarshie A, Hsu LL, Sayavongsa P, Perry J, Jackson EM, Hibbert JM. C-reactive protein and interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet. J Nutr. 2008;138:1148\u20131152.", "ArticleIdList": ["PMC3755955", "18492848"]}, {"Citation": "Romero JR, Suzuka SM, Nagel RL, Fabry ME. Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity. Blood. 2002;99:1103\u20131108. doi: 10.1182/blood.V99.4.1103.", "ArticleIdList": ["10.1182/blood.V99.4.1103", "11830454"]}, {"Citation": "Morris CR. Alterations of the arginine metabolome in sickle cell disease: a growing rationale for arginine therapy. Hematol Oncol Clin North Am. 2014;28:301\u2013321. doi: 10.1016/j.hoc.2013.11.008.", "ArticleIdList": ["10.1016/j.hoc.2013.11.008", "24589268"]}, {"Citation": "Bakshi N, Morris CR. The role of the arginine metabolome in pain: implications for sickle cell disease. J Pain Res. 2016;9:167\u2013175.", "ArticleIdList": ["PMC4821376", "27099528"]}, {"Citation": "Chang TP, Kriengsoontorkij W, Chan LS, Wang VJ. Clinical factors and incidence of acute chest syndrome or pneumonia among children with sickle cell disease presenting with a fever: a 17-year review. Pediatr Emerg Care. 2013;29:781\u2013786. doi: 10.1097/PEC.0b013e31829829f7.", "ArticleIdList": ["10.1097/PEC.0b013e31829829f7", "23823253"]}, {"Citation": "Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, et al. Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PLoS One. 2014;9:e99489. doi: 10.1371/journal.pone.0099489.", "ArticleIdList": ["10.1371/journal.pone.0099489", "PMC4079316", "24988120"]}, {"Citation": "Enwonwu CO, Xu XX, Turner E. Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine. Am J Med Sci. 1990;300:366\u2013371. doi: 10.1097/00000441-199012000-00005.", "ArticleIdList": ["10.1097/00000441-199012000-00005", "2264574"]}, {"Citation": "Lopez BL, Kreshak AA, Morris CR, Davis-Moon L, Ballas SK, Ma XL. L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department. Br J Haematol. 2003;120:532\u2013534. doi: 10.1046/j.1365-2141.2003.04109.x.", "ArticleIdList": ["10.1046/j.1365-2141.2003.04109.x", "12580975"]}, {"Citation": "Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A. 1996;93:6770\u20136774. doi: 10.1073/pnas.93.13.6770.", "ArticleIdList": ["10.1073/pnas.93.13.6770", "PMC39102", "8692893"]}, {"Citation": "Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood. 2007;110:2166\u20132172. doi: 10.1182/blood-2006-12-061697.", "ArticleIdList": ["10.1182/blood-2006-12-061697", "PMC1976348", "17536019"]}, {"Citation": "Prasad AS, Kaplan J, Brewer GJ, Dardenne M. Immunological effects of zinc deficiency in sickle cell anemia (SCA) Prog Clin Biol Res. 1989;319:629\u2013647.", "ArticleIdList": ["2695940"]}, {"Citation": "Prasad AS. Zinc deficiency in patients with sickle cell disease. Am J Clin Nutr. 2002;75:181\u2013182.", "ArticleIdList": ["11815307"]}, {"Citation": "Zemel BS, Kawchak DA, Fung EB, Ohene-Frempong K, Stallings VA. Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr. 2002;75:300\u2013307.", "ArticleIdList": ["11815322"]}, {"Citation": "Zehtabchi S, Sinert R, Rinnert S, Chang B, Heinis C, Altura RA, Altura BT, Altura BM. Serum ionized magnesium levels and ionized calcium-to-magnesium ratios in adult patients with sickle cell anemia. Am J Hematol. 2004;77:215\u2013222. doi: 10.1002/ajh.20187.", "ArticleIdList": ["10.1002/ajh.20187", "15495259"]}, {"Citation": "Oladipo OO, Temiye EO, Ezeaka VC, Obomanu P. Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease. West Afr J Med. 2005;24:120\u2013123.", "ArticleIdList": ["16092311"]}, {"Citation": "Okochi VI, Okpurzor J. Micronutrients as therapeutic tools in the management of sickle cell disease, malaria and diabetes. Afr J Biotechnol. 2005;4:1568\u20131579."}, {"Citation": "Das AK. A textbook on medinicinal aspects of Bio-inorganic Chemistry. 1st edition CBS Publishers and Distributors India. 1990, 5-9."}, {"Citation": "Jang JE, Hidalgo A, Frenette PS. Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcgammaRIII and SHP-1. Circ Res. 2012;110:1057\u20131066. doi: 10.1161/CIRCRESAHA.112.266411.", "ArticleIdList": ["10.1161/CIRCRESAHA.112.266411", "PMC3351009", "22415018"]}, {"Citation": "Chang J, Patton JT, Sarkar A, Ernst B, Magnani JL, Frenette PS. GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice. Blood. 2010;116:1779\u20131786. doi: 10.1182/blood-2009-12-260513.", "ArticleIdList": ["10.1182/blood-2009-12-260513", "PMC2947397", "20508165"]}, {"Citation": "Williams R, George EO, Wang W. Nutrition assessment in children with sickle cell disease. J Assoc Acad Minor Phys. 1997;8:44\u201348.", "ArticleIdList": ["9271889"]}, {"Citation": "Tangney CC, Phillips G, Bell RA, Fernandes P, Hopkins R, Wu SM. Selected indices of micronutrient status in adult patients with sickle cell anemia (SCA) Am J Hematol. 1989;32:161\u2013166. doi: 10.1002/ajh.2830320302.", "ArticleIdList": ["10.1002/ajh.2830320302", "2816908"]}, {"Citation": "Klings ES, Farber HW. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res. 2001;2:280\u2013285. doi: 10.1186/rr70.", "ArticleIdList": ["10.1186/rr70", "PMC59517", "11686897"]}, {"Citation": "Muskiet FA, Muskiet FD, Meiborg G, Schermer JG. Supplementation of patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean oil, and fish oil. Am J Clin Nutr. 1991;54:736\u2013744.", "ArticleIdList": ["1716847"]}, {"Citation": "Jaja SI, Aigbe PE, Gbenebitse S, Temiye EO. Changes in erythrocytes following supplementation with alpha-tocopherol in children suffering from sickle cell anaemia. Niger Postgrad Med J. 2005;12:110\u2013114.", "ArticleIdList": ["15997260"]}, {"Citation": "Jaja SI, Ikotun AR, Gbenebitse S, Temiye EO. Blood pressure, hematologic and erythrocyte fragility changes in children suffering from sickle cell anemia following ascorbic acid supplementation. J Trop Pediatr. 2002;48:366\u2013370. doi: 10.1093/tropej/48.6.366.", "ArticleIdList": ["10.1093/tropej/48.6.366", "12521281"]}, {"Citation": "Imaga NA. Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia. Sci World J. 2013;2013:269659. doi: 10.1155/2013/269659.", "ArticleIdList": ["10.1155/2013/269659", "PMC3586489", "23476125"]}, {"Citation": "Al-Momen AK. Diminished vitamin B12 levels in patients with severe sickle cell disease. J Intern Med. 1995;237:551\u2013555. doi: 10.1111/j.1365-2796.1995.tb00884.x.", "ArticleIdList": ["10.1111/j.1365-2796.1995.tb00884.x", "7782726"]}, {"Citation": "Arlet JB, Courbebaisse M, Chatellier G, Eladari D, Souberbielle JC, Friedlander G, de Montalembert M, Prie D, Pouchot J, Ribeil JA. Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults. Bone. 2013;52:206\u2013211. doi: 10.1016/j.bone.2012.10.005.", "ArticleIdList": ["10.1016/j.bone.2012.10.005", "23072921"]}, {"Citation": "Hyacinth HI, Gee BE, Hibbert JM. The Role of Nutrition in Sickle Cell Disease. Nutr Metab Insights. 2010;3:57\u201367. doi: 10.4137/NMI.S5048.", "ArticleIdList": ["10.4137/NMI.S5048", "PMC3085005", "21537370"]}, {"Citation": "Hyacinth HI, Adekeye OA, Yilgwan CS. Malnutrition in Sickle Cell Anemia: Implications for Infection, Growth, and Maturation. J Soc Behav Health Sci. 2013;7. http://scholarworks.waldenu.edu/jsbhs/vol7/iss1/2/", "ArticleIdList": ["PMC3848498", "24312698"]}, {"Citation": "Hibbert JM, Creary MS, Gee BE, Buchanan ID, Quarshie A, Hsu LL. Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia. J Pediatr Gastroenterol Nutr. 2006;43:680\u2013687. doi: 10.1097/01.mpg.0000228120.44606.d6.", "ArticleIdList": ["10.1097/01.mpg.0000228120.44606.d6", "PMC4084935", "17130748"]}, {"Citation": "Barden EM, Zemel BS, Kawchak DA, Goran MI, Ohene-Frempong K, Stallings VA. Total and resting energy expenditure in children with sickle cell disease. J Pediatr. 2000;136:73\u201379. doi: 10.1016/S0022-3476(00)90053-2.", "ArticleIdList": ["10.1016/S0022-3476(00)90053-2", "10636978"]}, {"Citation": "Taylor SC, Shacks SJ, Qu Z, Wiley P. Type 2 cytokine serum levels in healthy sickle cell disease patients. J Natl Med Assoc. 1997;89:753\u2013757.", "ArticleIdList": ["PMC2608277", "9375480"]}, {"Citation": "Singhal A, Parker S, Linsell L, Serjeant G. Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease. Am J Clin Nutr. 2002;75:1093\u20131097.", "ArticleIdList": ["12036818"]}, {"Citation": "Strasser F, Bruera ED. Update on anorexia and cachexia. Hematol Oncol Clin North Am. 2002;16:589\u2013617. doi: 10.1016/S0889-8588(02)00011-4.", "ArticleIdList": ["10.1016/S0889-8588(02)00011-4", "12170570"]}, {"Citation": "Taylor SC, Shacks SJ, Mitchell RA, Banks A. Serum interleukin-6 levels in the steady state of sickle cell disease. J Interferon Cytokine Res. 1995;15:1061\u20131064. doi: 10.1089/jir.1995.15.27.", "ArticleIdList": ["10.1089/jir.1995.15.27", "8746787"]}, {"Citation": "Richardson RA, Davidson HI. Nutritional demands in acute and chronic illness. Proc Nutr Soc. 2003;62:777\u2013781. doi: 10.1079/PNS2003302.", "ArticleIdList": ["10.1079/PNS2003302", "15018475"]}, {"Citation": "Laviano A, Renvyle T, Meguid MM, Yang ZJ, Cangiano C, Rossi Fanelli F. Relationship between interleukin-1 and cancer anorexia. Nutrition. 1995;11:680\u2013683.", "ArticleIdList": ["8748251"]}, {"Citation": "Turrin NP, Ilyin SE, Gayle DA, Plata-Salaman CR, Ramos EJ, Laviano A, Das UN, Inui A, Meguid MM. Interleukin-1beta system in anorectic catabolic tumor-bearing rats. Curr Opin Clin Nutr Metab Care. 2004;7:419\u2013426. doi: 10.1097/01.mco.0000134373.16557.92.", "ArticleIdList": ["10.1097/01.mco.0000134373.16557.92", "15192445"]}, {"Citation": "Perboni S, Inui A. Anorexia in cancer: role of feeding-regulatory peptides. Philos Trans R Soc Lond B Biol Sci. 2006;361:1281\u20131289. doi: 10.1098/rstb.2006.1863.", "ArticleIdList": ["10.1098/rstb.2006.1863", "PMC1642704", "16815804"]}, {"Citation": "Lemanek KL, Brown RT, Amstrong FD, Hood C, Pegelow C, Woods G. Dysfunctional eating patterns and symptoms of pica in children and adolescents with sickle cell disease. Clin Pediatr (Phila) 2002;41:493\u2013500. doi: 10.1177/000992280204100706.", "ArticleIdList": ["10.1177/000992280204100706", "12365311"]}, {"Citation": "Oniyangi O, Cohall DH. Phytomedicines (medicines derived from plants) for sickle cell disease. Cochrane Database Syst Rev. 2015;4:CD004448.", "ArticleIdList": ["25844571"]}, {"Citation": "Connor WE, Lin DS, Thomas G, Ey F, DeLoughery T, Zhu N. Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia. J Lipid Res. 1997;38:2516\u20132528.", "ArticleIdList": ["9458275"]}, {"Citation": "Agoreyo F, Nwanze N. Plasma sodium and potassium changes in sickle cell patients. Int J Genet Mol Biol. 2010;2:14\u201319."}, {"Citation": "Bao B, Prasad AS, Beck FW, Snell D, Suneja A, Sarkar FH, Doshi N, Fitzgerald JT, Swerdlow P. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Transl Res. 2008;152:67\u201380. doi: 10.1016/j.trsl.2008.06.001.", "ArticleIdList": ["10.1016/j.trsl.2008.06.001", "18674741"]}, {"Citation": "Mpiana PT, Mudogo V, Tshibangu DS, Kitwa EK, Kanangila AB, Lumbu JB, Ngbolua KN, Atibu EK, Kakule MK. Antisickling activity of anthocyanins from Bombax pentadrum, Ficus capensis and Ziziphus mucronata: photodegradation effect. J Ethnopharmacol. 2008;120:413\u2013418. doi: 10.1016/j.jep.2008.09.012.", "ArticleIdList": ["10.1016/j.jep.2008.09.012", "18930798"]}, {"Citation": "Mpiana PT, Ngbolua KN, Bokota MT, Kasonga TK, Atibu EK, Tshibangu DS, Mudogo V. In vitro effects of anthocyanin extracts from Justicia secunda Vahl on the solubility of haemoglobin S and membrane stability of sickle erythrocytes. Blood Transfus. 2010;8:248\u2013254.", "ArticleIdList": ["PMC2957489", "20967165"]}, {"Citation": "Ameh SJ, Tarfa FD, Ebeshi BU. Traditional herbal management of sickle cell anemia: lessons from Nigeria. Anemia. 2012;2012:607436. doi: 10.1155/2012/607436.", "ArticleIdList": ["10.1155/2012/607436", "PMC3502758", "23198140"]}, {"Citation": "Ray D, Deshmukh P, Goswami K, Garg N. Antioxidant vitamin levels in sickle cell disorders. Natl Med J India. 2007;20:11\u201313.", "ArticleIdList": ["17557515"]}, {"Citation": "Lachant NA, Tanaka KR. Antioxidants in sickle cell disease: the in vitro effects of ascorbic acid. Am J Med Sci. 1986;292:3\u201310. doi: 10.1097/00000441-198607000-00001.", "ArticleIdList": ["10.1097/00000441-198607000-00001", "3521279"]}, {"Citation": "Silva DG, Belini Junior E, de Almeida EA, Bonini-Domingos CR. Oxidative stress in sickle cell disease: an overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies. Free Radic Biol Med. 2013;65:1101\u20131109. doi: 10.1016/j.freeradbiomed.2013.08.181.", "ArticleIdList": ["10.1016/j.freeradbiomed.2013.08.181", "24002011"]}, {"Citation": "Fasola F, Adedapo K, Anetor J, Kuti M. Total antioxidants status and some hematological values in sickle cell disease patients in steady state. J Natl Med Assoc. 2007;99:891\u2013894.", "ArticleIdList": ["PMC2574295", "17722666"]}, {"Citation": "Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life. 2012;64:72\u201380. doi: 10.1002/iub.584.", "ArticleIdList": ["10.1002/iub.584", "22131167"]}, {"Citation": "Wright D, Reid M, Stennett R. Antioxidant intake in sickle cell disease. Int J Clin Nutr. 2014;2:53\u201359."}, {"Citation": "Pace BS, White GL, Dover GJ, Boosalis MS, Faller DV, Perrine SP. Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood. 2002;100:4640\u20134648. doi: 10.1182/blood-2002-02-0353.", "ArticleIdList": ["10.1182/blood-2002-02-0353", "PMC4269367", "12393583"]}, {"Citation": "Westerman MP, Zhang Y, McConnell JP, Chezick PA, Neelam R, Freels S, Feldman LS, Allen S, Baridi R, Feldman LE, Fung LW. Ascorbate levels in red blood cells and urine in patients with sickle cell anemia. Am J Hematol. 2000;65:174\u2013175. doi: 10.1002/1096-8652(200010)65:2<174::AID-AJH15>3.0.CO;2-T.", "ArticleIdList": ["10.1002/1096-8652(200010)65:2<174::AID-AJH15>3.0.CO;2-T", "10996838"]}, {"Citation": "Tomer A, Kasey S, Connor WE, Clark S, Harker LA, Eckman JR. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost. 2001;85:966\u2013974.", "ArticleIdList": ["11434703"]}, {"Citation": "Okpala I, Ibegbulam O, Duru A, Ocheni S, Emodi I, Ikefuna A, Umar G, Asinobi I, Madu A, Okoye A, et al. Pilot study of omega-3 fatty acid supplements in sickle cell disease. APMIS. 2011;119:442\u2013448. doi: 10.1111/j.1600-0463.2011.02751.x.", "ArticleIdList": ["10.1111/j.1600-0463.2011.02751.x", "21635551"]}, {"Citation": "Calder PC. Dietary fatty acids and lymphocyte functions. Proc Nutr Soc. 1998;57:487\u2013502. doi: 10.1079/PNS19980073.", "ArticleIdList": ["10.1079/PNS19980073", "10096108"]}, {"Citation": "Ren H, Obike I, Okpala I, Ghebremeskel K, Ugochukwu C, Crawford M. Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2005;72:415\u2013421. doi: 10.1016/j.plefa.2005.03.005.", "ArticleIdList": ["10.1016/j.plefa.2005.03.005", "15876528"]}, {"Citation": "Ren H, Okpala I, Ghebremeskel K, Ugochukwu CC, Ibegbulam O, Crawford M. Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease. Ann Hematol. 2005;84:578\u2013583. doi: 10.1007/s00277-005-1023-7.", "ArticleIdList": ["10.1007/s00277-005-1023-7", "15809883"]}, {"Citation": "Abraham DJ, Mehanna AS, Williams FL. Design, synthesis, and testing of potential antisickling agents. 1. Halogenated benzyloxy and phenoxy acids. J Med Chem. 1982;25:1015\u20131017. doi: 10.1021/jm00351a002.", "ArticleIdList": ["10.1021/jm00351a002", "7131479"]}, {"Citation": "Ogoda Onah J, Akubue PI, Okide GB. The kinetics of reversal of pre-sickled erythrocytes by the aqueous extract of Cajanus cajan seeds. Phytother Res. 2002;16:748\u2013750. doi: 10.1002/ptr.1026.", "ArticleIdList": ["10.1002/ptr.1026", "12458479"]}, {"Citation": "Abdulmalik O, Safo MK, Chen Q, Yang J, Brugnara C, Ohene-Frempong K, Abraham DJ, Asakura T. 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells. Br J Haematol. 2005;128:552\u2013561. doi: 10.1111/j.1365-2141.2004.05332.x.", "ArticleIdList": ["10.1111/j.1365-2141.2004.05332.x", "15686467"]}, {"Citation": "Akojie FO, Fung LW. Antisickling activity of hydroxybenzoic acids in Cajanus cajan. Planta Med. 1992;58:317\u2013320. doi: 10.1055/s-2006-961475.", "ArticleIdList": ["10.1055/s-2006-961475", "1438591"]}, {"Citation": "Acquaye CT, Young JD, Ellory JC, Gorecki M, Wilchek M. Mode of transport and possible mechanism of action of L-phenylalanine benzyl ester as an anti-sickling agent. Biochim Biophys Acta. 1982;693:407\u2013416. doi: 10.1016/0005-2736(82)90448-5.", "ArticleIdList": ["10.1016/0005-2736(82)90448-5", "7159585"]}, {"Citation": "Nabipour S, Ayu Said M, Hussain Habil M. Burden and nutritional deficiencies in opiate addiction- systematic review article. Iran J Public Health. 2014;43:1022\u20131032.", "ArticleIdList": ["PMC4411899", "25927032"]}, {"Citation": "Ballas SK, Marcolina MJ. Determinants of red cell survival and erythropoietic activity in patients with sickle cell anemia in the steady state. Hemoglobin. 2000;24:277\u2013286. doi: 10.3109/03630260008993134.", "ArticleIdList": ["10.3109/03630260008993134", "11186257"]}, {"Citation": "Edwards C, Whitfield K, Sudhakar S, Pearce M, Byrd G, Wood M, Feliu M, Leach-Beale B, DeCastro L, Whitworth E, et al. Parental substance abuse, reports of chronic pain and coping in adult patients with sickle cell disease. J Natl Med Assoc. 2006;98:420\u2013428.", "ArticleIdList": ["PMC2576131", "16573309"]}, {"Citation": "Borland ML, Clark LJ, Esson A. Comparative review of the clinical use of intranasal fentanyl versus morphine in a paediatric emergency department. Emerg Med Australas. 2008;20:515\u2013520. doi: 10.1111/j.1742-6723.2008.01138.x.", "ArticleIdList": ["10.1111/j.1742-6723.2008.01138.x", "19125831"]}, {"Citation": "Tofukuji M, Metais C, Wang SY, Alper SL, Sellke FW. Clotrimazole is a potent vasodilator of the rat coronary microcirculation. J Surg Res. 1998;77:6\u201310. doi: 10.1006/jsre.1998.5320.", "ArticleIdList": ["10.1006/jsre.1998.5320", "9698524"]}, {"Citation": "Bocci V. The case for oxygen-ozonetherapy. Br J Biomed Sci. 2007;64:44\u201349. doi: 10.1080/09674845.2007.11732755.", "ArticleIdList": ["10.1080/09674845.2007.11732755", "17444419"]}, {"Citation": "Bocci V, Aldinucci C, Mosci F, Carraro F, Valacchi G. Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70. Mediators Inflamm. 2007;2007:26785. doi: 10.1155/2007/26785.", "ArticleIdList": ["10.1155/2007/26785", "PMC2233812", "18274635"]}, {"Citation": "Hoban MD, Orkin SH, Bauer DE. Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease. Blood. 2016;127(7):839\u201348. doi: 10.1182/blood-2015-09-618587.", "ArticleIdList": ["10.1182/blood-2015-09-618587", "PMC4760089", "26758916"]}, {"Citation": "Pestina TI, Hargrove PW, Zhao H, Mead PE, Smeltzer MP, Weiss MJ, Wilber A, Persons DA. Amelioration of murine sickle cell disease by nonablative conditioning and gamma-globin gene-corrected bone marrow cells. Mol Ther Methods Clin Dev. 2015;2:15045. doi: 10.1038/mtm.2015.45.", "ArticleIdList": ["10.1038/mtm.2015.45", "PMC4667717", "26665131"]}, {"Citation": "Caboot JB, Allen JL. Hypoxemia in sickle cell disease: significance and management. Paediatr Respir Rev. 2014;15:17\u201323.", "ArticleIdList": ["24461342"]}, {"Citation": "Friedman M, Wilson M, Lin HC, Chang HW. Updated systematic review of tonsillectomy and adenoidectomy for treatment of pediatric obstructive sleep apnea/hypopnea syndrome. Otolaryngol Head Neck Surg. 2009;140:800\u2013808. doi: 10.1016/j.otohns.2009.01.043.", "ArticleIdList": ["10.1016/j.otohns.2009.01.043", "19467393"]}, {"Citation": "Needleman JP, Setty BN, Varlotta L, Dampier C, Allen JL. Measurement of hemoglobin saturation by oxygen in children and adolescents with sickle cell disease. Pediatr Pulmonol. 1999;28:423\u2013428. doi: 10.1002/(SICI)1099-0496(199912)28:6<423::AID-PPUL7>3.0.CO;2-C.", "ArticleIdList": ["10.1002/(SICI)1099-0496(199912)28:6<423::AID-PPUL7>3.0.CO;2-C", "10587417"]}, {"Citation": "Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med. 1995;333:699\u2013703. doi: 10.1056/NEJM199509143331104.", "ArticleIdList": ["10.1056/NEJM199509143331104", "7637747"]}, {"Citation": "Hsu LL, Batts BK, Rau JL. Positive expiratory pressure device acceptance by hospitalized children with sickle cell disease is comparable to incentive spirometry. Respir Care. 2005;50:624\u2013627.", "ArticleIdList": ["15871756"]}, {"Citation": "Kovacic P. Hydroxyurea (therapeutics and mechanism): metabolism, carbamoyl nitroso, nitroxyl, radicals, cell signaling and clinical applications. Med Hypotheses. 2011;76:24\u201331. doi: 10.1016/j.mehy.2010.08.023.", "ArticleIdList": ["10.1016/j.mehy.2010.08.023", "20833482"]}, {"Citation": "Snyder AR, Zhou J, Deng Z, Lieberman PM. Therapeutic doses of hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres. Cancer Biol Ther. 2009;8:1136\u20131145. doi: 10.4161/cbt.8.12.8446.", "ArticleIdList": ["10.4161/cbt.8.12.8446", "PMC3313557", "19363303"]}, {"Citation": "Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457\u2013463. doi: 10.1038/nature02625.", "ArticleIdList": ["10.1038/nature02625", "15164071"]}, {"Citation": "Reid ME, El Beshlawy A, Inati A, Kutlar A, Abboud MR, Haynes J, Jr, Ward R, Sharon B, Taher AT, Smith W, et al. A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2014;89:709\u2013713. doi: 10.1002/ajh.23725.", "ArticleIdList": ["10.1002/ajh.23725", "24677033"]}, {"Citation": "Steliou K, Boosalis MS, Perrine SP, Sangerman J, Faller DV. Butyrate histone deacetylase inhibitors. Biores Open Access. 2012;1:192\u2013198. doi: 10.1089/biores.2012.0223.", "ArticleIdList": ["10.1089/biores.2012.0223", "PMC3559235", "23514803"]}, {"Citation": "Saunthararajah Y, Hillery CA, Lavelle D, Molokie R, Dorn L, Bressler L, Gavazova S, Chen YH, Hoffman R, DeSimone J. Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Blood. 2003;102:3865\u20133870. doi: 10.1182/blood-2003-05-1738.", "ArticleIdList": ["10.1182/blood-2003-05-1738", "12907443"]}, {"Citation": "Hebbel RP, Vercellotti GM, Pace BS, Solovey AN, Kollander R, Abanonu CF, Nguyen J, Vineyard JV, Belcher JD, Abdulla F, et al. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. Blood. 2010;115:2483\u20132490. doi: 10.1182/blood-2009-02-204990.", "ArticleIdList": ["10.1182/blood-2009-02-204990", "PMC2845902", "20053759"]}, {"Citation": "Meiler SE, Wade M, Kutlar F, Yerigenahally SD, Xue Y, Moutouh-de Parseval LA, Corral LG, Swerdlow PS, Kutlar A. Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice. Blood. 2011;118:1109\u20131112. doi: 10.1182/blood-2010-11-319137.", "ArticleIdList": ["10.1182/blood-2010-11-319137", "PMC3148160", "21536862"]}, {"Citation": "Ataga KI, Stocker J. Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia. Expert Opin Investig Drugs. 2009;18:231\u2013239. doi: 10.1517/13543780802708011.", "ArticleIdList": ["10.1517/13543780802708011", "19236269"]}, {"Citation": "Morris CR, Kim HY, Wood J, Porter JB, Klings ES, Trachtenberg FL, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, et al. Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica. 2013;98:1359\u20131367. doi: 10.3324/haematol.2012.082065.", "ArticleIdList": ["10.3324/haematol.2012.082065", "PMC3762091", "23585527"]}, {"Citation": "Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA. Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. Thromb Haemost. 2007;98:392\u2013396.", "ArticleIdList": ["17721622"]}, {"Citation": "Katusic ZS, d'Uscio LV, Nath KA. Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol Sci. 2009;30:48\u201354. doi: 10.1016/j.tips.2008.10.003.", "ArticleIdList": ["10.1016/j.tips.2008.10.003", "PMC2637534", "19042039"]}, {"Citation": "Belfer I, Youngblood V, Darbari DS, Wang Z, Diaw L, Freeman L, Desai K, Dizon M, Allen D, Cunnington C, et al. A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia. Am J Hematol. 2014;89:187\u2013193. doi: 10.1002/ajh.23613.", "ArticleIdList": ["10.1002/ajh.23613", "PMC4281092", "24136375"]}, {"Citation": "Desai PC, Brittain JE, Jones SK, McDonald A, Wilson DR, Dominik R, Key NS, Parise LV, Ataga KI. A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease. Thromb Res. 2013;132:341\u2013345. doi: 10.1016/j.thromres.2013.08.002.", "ArticleIdList": ["10.1016/j.thromres.2013.08.002", "PMC3791139", "23973010"]}, {"Citation": "Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L. A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol. 2011;153:655\u2013663. doi: 10.1111/j.1365-2141.2010.08480.x.", "ArticleIdList": ["10.1111/j.1365-2141.2010.08480.x", "PMC3601917", "21477202"]}, {"Citation": "Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168\u2013186. doi: 10.1182/blood-2009-06-225565.", "ArticleIdList": ["10.1182/blood-2009-06-225565", "19846889"]}, {"Citation": "Turhan A, Jenab P, Bruhns P, Ravetch JV, Coller BS, Frenette PS. Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes. Blood. 2004;103:2397\u20132400. doi: 10.1182/blood-2003-07-2209.", "ArticleIdList": ["10.1182/blood-2003-07-2209", "14630831"]}, {"Citation": "Chang J, Shi PA, Chiang EY, Frenette PS. Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion. Blood. 2008;111:915\u2013923. doi: 10.1182/blood-2007-04-084061.", "ArticleIdList": ["10.1182/blood-2007-04-084061", "PMC2200843", "17932253"]}, {"Citation": "Zennadi R, Moeller BJ, Whalen EJ, Batchvarova M, Xu K, Shan S, Delahunty M, Dewhirst MW, Telen MJ. Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo. Blood. 2007;110:2708\u20132717. doi: 10.1182/blood-2006-11-056101.", "ArticleIdList": ["10.1182/blood-2006-11-056101", "PMC1988948", "17609430"]}, {"Citation": "Field JJ, Lin G, Okam MM, Majerus E, Keefer J, Onyekwere O, Ross A, Campigotto F, Neuberg D, Linden J, Nathan DG. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013;121:3329\u20133334. doi: 10.1182/blood-2012-11-465963.", "ArticleIdList": ["10.1182/blood-2012-11-465963", "PMC3637009", "23377438"]}, {"Citation": "Kuvibidila S, Baliga BS, Gardner R, Yu L, Warrier R, Velez M, Ode D, Haynes J. Differential effects of hydroxyurea and zileuton on interleukin-13 secretion by activated murine spleen cells: implication on the expression of vascular cell adhesion molecule-1 and vasoocclusion in sickle cell anemia. Cytokine. 2005;30:213\u2013218. doi: 10.1016/j.cyto.2005.01.010.", "ArticleIdList": ["10.1016/j.cyto.2005.01.010", "15927844"]}, {"Citation": "Marangos PJ, Fox AW, Riedel BJ, Royston D, Dziewanowska ZE. Potential therapeutic applications of fructose-1,6-diphosphate. Expert Opin Investig Drugs. 1998;7:615\u2013623. doi: 10.1517/13543784.7.4.615.", "ArticleIdList": ["10.1517/13543784.7.4.615", "15991998"]}, {"Citation": "Wun T, Soulieres D, Frelinger AL, Krishnamurti L, Novelli EM, Kutlar A, Ataga KI, Knupp CL, McMahon LE, Strouse JJ, et al. A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease. J Hematol Oncol. 2013;6:17. doi: 10.1186/1756-8722-6-17.", "ArticleIdList": ["10.1186/1756-8722-6-17", "PMC3585853", "23414938"]}, {"Citation": "Beckman JD, Belcher JD, Vineyard JV, Chen C, Nguyen J, Nwaneri MO, O'Sullivan MG, Gulbahce E, Hebbel RP, Vercellotti GM. Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. Am J Physiol Heart Circ Physiol. 2009;297:H1243\u20131253. doi: 10.1152/ajpheart.00327.2009.", "ArticleIdList": ["10.1152/ajpheart.00327.2009", "PMC2770753", "19617415"]}, {"Citation": "Martins VD, Manfredini V, Peralba MC, Benfato MS. Alpha-lipoic acid modifies oxidative stress parameters in sickle cell trait subjects and sickle cell patients. Clin Nutr. 2009;28:192\u2013197. doi: 10.1016/j.clnu.2009.01.017.", "ArticleIdList": ["10.1016/j.clnu.2009.01.017", "19231043"]}, {"Citation": "Pace BS, Shartava A, Pack-Mabien A, Mulekar M, Ardia A, Goodman SR. Effects of N-acetylcysteine on dense cell formation in sickle cell disease. Am J Hematol. 2003;73:26\u201332. doi: 10.1002/ajh.10321.", "ArticleIdList": ["10.1002/ajh.10321", "12701116"]}, {"Citation": "Niihara Y, Matsui NM, Shen YM, Akiyama DA, Johnson CS, Sunga MA, Magpayo J, Embury SH, Kalra VK, Cho SH, Tanaka KR. L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells. BMC Blood Disord. 2005;5:4.", "ArticleIdList": ["PMC1198219", "16042803"]}, {"Citation": "Brousseau DC, Scott JP, Hillery CA, Panepinto JA. The effect of magnesium on length of stay for pediatric sickle cell pain crisis. Acad Emerg Med. 2004;11:968\u2013972. doi: 10.1111/j.1553-2712.2004.tb00791.x.", "ArticleIdList": ["10.1111/j.1553-2712.2004.tb00791.x", "15347549"]}, {"Citation": "Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM. Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. Hemoglobin. 2004;28:85\u2013102. doi: 10.1081/HEM-120035919.", "ArticleIdList": ["10.1081/HEM-120035919", "15182051"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "3", "Day": "20"}, {"Year": "2016", "Month": "7", "Day": "22"}, {"Year": "2016", "Month": "8", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "8", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "8", "Day": "11", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "8", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["27508000", "PMC4977632", "10.1186/s12986-016-0109-7", "109"]}}], "PubmedBookArticle": []}